Business combination progress payments paid under collaboration agreement.

No definition available.

Name:	hznp_BusinessCombinationProgressPaymentsPaidUnderCollaborationAgreement
Namespace Prefix:	hznp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Business combination upfront payment.

+ References

No definition available.

+ Details

Name:	hznp_BusinessCombinationUpfrontPayment
Namespace Prefix:	hznp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Disposal group not discontinued operation contingent consideration payment.

+ References

No definition available.

+ Details

Name:	hznp_DisposalGroupNotDiscontinuedOperationContingentConsiderationPayment
Namespace Prefix:	hznp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Milestone and royalty payments.

+ References

No definition available.

+ Details

Name:	hznp_MilestoneAndRoyaltyPayments
Namespace Prefix:	hznp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Milestone payment under license agreement.

+ References

No definition available.

+ Details

Name:	hznp_MilestonePaymentUnderLicenseAgreement
Namespace Prefix:	hznp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage of net sales in earn-out payment.

+ References

No definition available.

+ Details

Name:	hznp_PercentageOfNetSalesInEarnOutPayment
Namespace Prefix:	hznp_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Sales revenue net minimum limit for royalty payment.

+ References

No definition available.

+ Details

Name:	hznp_SalesRevenueNetMinimumLimitForRoyaltyPayment
Namespace Prefix:	hznp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Date when the business acquisition agreement was executed, in CCYY-MM-DD format.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585

+ Details

Name:	us-gaap_CashAcquiredFromAcquisition
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

+ Details

Name:	us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.

+ References

+ Details

Name:	us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901

+ Details

Name:	us-gaap_ForeignCurrencyExchangeRateTranslation1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585

+ Details

Name:	us-gaap_ProceedsFromSaleOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319

+ Details

Name:	us-gaap_TaxCreditCarryforwardAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	srt_ProductOrServiceAxis=hznp_TEPEZZAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=hznp_RiverVisionDevelopmentCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=hznp_USFoodAndDrugAdministrationFDAApprovalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=hznp_NetSalesThresholdsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=hznp_TeprotumumabMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=hznp_HemoShearTherapeuticsLimitedLiabilityCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hznp_RocheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hznp_SROneAndLundbeckfondMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupNotDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hznp_CosettePharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hznp_MIGERGOTTransactionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Acquisitions, Divestitures and Other Arrangements - Additional Information (Detail)			1 Months Ended			3 Months Ended				6 Months Ended
	Jun. 28, 2019 USD ($)	May 08, 2017 USD ($)	Jul. 31, 2020 USD ($)	Apr. 30, 2020 USD ($)	Jul. 31, 2019 USD ($)	Jun. 30, 2020 USD ($) $ / SFr $ / €	Jun. 30, 2020 CHF (SFr)	Mar. 31, 2020 USD ($) $ / SFr	Mar. 31, 2020 CHF (SFr) $ / SFr	Jun. 30, 2020 USD ($) $ / SFr $ / €	Jun. 30, 2020 CHF (SFr)	Jun. 30, 2020 CHF (SFr) $ / SFr $ / €	Dec. 31, 2019 USD ($)	Jan. 03, 2019 USD ($)
Business Acquisition [Line Items]
Upfront cash payments										$ 262,305,000
Currency exchange rate \| $ / €						1.1236				1.1236		1.1236
Milestone and royalty payments				$ 55,000,000.0
Developed technology and other intangible assets, net						$ 1,891,100,000				$ 1,891,100,000			$ 1,702,628,000
TEPEZZA [Member]
Business Acquisition [Line Items]
Developed technology and other intangible assets, net						98,700,000				98,700,000
River Vision [Member]
Business Acquisition [Line Items]
Percentage of equity interests acquired		100.00%
Business acquisition agreement date		May 08, 2017
Upfront cash payments		$ 150,300,000
Cash acquired from acquisition		6,300,000
Federal net operating losses		32,400,000
State net operating losses		2,200,000
Federal tax credits		$ 9,500,000
Maximum payment to be made upon attainment of milestones						325,000,000.0				$ 325,000,000.0
Percentage of net sales in earn-out payment										3.00%	3.00%
Net sales minimum limit for royal payment										$ 300,000,000.0
River Vision [Member] \| TEPEZZA [Member]
Business Acquisition [Line Items]
Milestone incurred						67,000,000.0
River Vision [Member] \| U.S. Food and Drug Administration (FDA) Approval [Member]
Business Acquisition [Line Items]
Maximum payment to be made upon attainment of milestones						100,000,000.0				100,000,000.0
River Vision [Member] \| Net Sales Thresholds [Member] \| Teprotumumab [Member]
Business Acquisition [Line Items]
Maximum payment to be made upon attainment of milestones						225,000,000.0				225,000,000.0
HemoShear [Member]
Business Acquisition [Line Items]
Upfront cash payment														$ 2,000,000.0
Business combination progress payments paid under collaboration agreement.			$ 3,000,000.0		$ 4,000,000.0
Roche [Member]
Business Acquisition [Line Items]
Maximum payment to be made upon attainment of milestones						$ 108,700,000				108,700,000		SFr 103,000,000.0
Milestone incurred								$ 5,200,000	SFr 5,000,000.0	$ 5,200,000	SFr 5,000,000.0
Currency exchange rate \| $ / SFr						1.0382		1.0382	1.0382	1.0382		1.0382
Roche [Member] \| TEPEZZA [Member]
Business Acquisition [Line Items]
Milestone incurred						$ 31,700,000	SFr 30,000,000.0
Currency exchange rate \| $ / SFr						1.0556				1.0556		1.0556
S R One And Lundbeckfond
Business Acquisition [Line Items]
Developed technology and other intangible assets, net						$ 110,000,000.0				$ 110,000,000.0
Disposal Group, Not Discontinued Operations [Member] \| Cosette Pharmaceuticals, Inc [Member]
Business Acquisition [Line Items]
Rights sold for an upfront payment	$ 6,000,000.0
Disposal Group, Not Discontinued Operations [Member] \| Cosette Pharmaceuticals, Inc [Member] \| MIGERGOT Transaction [Member]
Business Acquisition [Line Items]
Potential additional contingent consideration payment	$ 4,000,000.0